Press releaseGlobe Newswire
Prokidney
PROK · NASDAQ
$1.44+$0.045 (+3.23%)TodayMarket closed ·
Prev close $1.40
Latest news
- Press releaseGlobe Newswire
ProKidney Reports Second Quarter 2026 Financial Results and Business Highlights
- Press releaseGlobe Newswire
ProKidney Appoints Kenneth Locke as Chief Technical Officer
- Press releaseGlobe Newswire
ProKidney Reports First Quarter 2026 Financial Results and Business Highlights
- Press releaseGlobe Newswire
ProKidney Expands Senior Leadership Team with Appointment of Greg Madison as Chief Commercial Officer
- Press releaseGlobe Newswire
ProKidney Reports Full Year 2025 Financial Results and Business Highlights
- Press releasePRNewswire
Chronic Kidney Disease Market Poised to Expand Significantly During Forecast Period (2025-2034) as Demand for Early Diagnosis and Novel Therapies Increases | DelveInsight
- Press releasePRNewswire
Beyond Insulin Pumps: Cell Therapies Unlock a $403B Cure Economy
- Press releaseGlobe Newswire
ProKidney Reports Third Quarter 2025 Financial Results and Provides Regulatory and Clinical Updates
- Press releaseGlobe Newswire
ProKidney Presents Full Results from the Phase 2 REGEN-007 Trial of Rilparencel at the American Society of Nephrology Kidney Week 2025
- NewsChris Katje
SPAC King Chamath Palihapitiya Tells Retail Investors To Stay Away From His New SPAC
- NewsChris Katje
Chamath Palihapitiya Returns To SPACs: Past 18 Deals, Investments Average Loss Of 14%
- News
Watching ProKidney Corp; Zacks Upgrades Stock To Strong Buy
- NewsAvi Kapoor
Simulations Plus, FB Financial And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
- NewsAvi Kapoor
AZZ Posts Better-Than-Expected Earnings, Joins MP Materials, WK Kellogg And Other Big Stocks Moving Higher On Thursday
- News
12 Health Care Stocks Moving In Thursday's Pre-Market Session
- NewsHenry Khederian
ProKidney (PROK) Shares Skyrocket On Promising Kidney Disease Drug Trial Results
- NewsAvi Kapoor
Verona Pharma, Rhythm Pharmaceuticals, AES And Other Big Stocks Moving Higher On Wednesday
- NewsRishabh Mishra
US Stocks Likely To Open Higher: Trump's Tariff Clock Ticks, Fed Likely To Keep Rates Unchanged
- NewsAvi Kapoor
Dow Tumbles Over 150 Points Amid Trump Tariffs: Investor Sentiment Declines, Fear Index Moves To 'Greed' Zone
- NewsMohd Haider
ProKidney Stock Shoots Up Over 8% After Hours After Staggering 515% Rally On Wednesday
- NewsShivdeep Dhaliwal
Prokidney, Soundhound AI, Quantumscape, Intel, And Nvidia: Why These 5 Stocks Are On Investors' Radars Today
- NewsAvi Kapoor
Gold Falls 1%; ProKidney Shares Spike Higher
- NewsAvi Kapoor
US Stocks Mixed; Small Business Sentiment Falls In June
- NewsVandana Singh
Why Is Penny Stock ProKidney Trading Higher On Tuesday?
- News
Market-Moving News for July 8th
- News
12 Health Care Stocks Moving In Thursday's After-Market Session
- NewsAvi Kapoor
Top 3 Health Care Stocks You'll Regret Missing This Quarter
- Press releasePRNewswire
Kuehn Law Encourages Investors of ProKidney Corp. to Contact Law Firm
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.